Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
48
# OF OVERLAPPING
HOLDINGS
XBI
139
HOLDINGS
35%
ALSO IN SBIO
SBIO
78
HOLDINGS
62%
ALSO IN XBI
SECTOR DRIFT (XBI minus SBIO)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
APELLIS PHARMACEUTICALS, INC. | 1.8% | 3.1% | 1.8% |
 |
ALKERMES PLC | 1.4% | 3.3% | 1.4% |
|
APOGEE THERAPEUTICS, INC. | 1.3% | 2.9% | 1.3% |
|
KYMERA THERAPEUTICS, INC. | 1.2% | 4.2% | 1.2% |
|
MIRUM PHARMACEUTICALS, INC. | 1.2% | 3.4% | 1.2% |
XBI Overweight Relative to SBIO
|
MADRIGAL PHARMACEUTICALS, INC. | 1.4% |
|
TG THERAPEUTICS INC | 1.4% |
|
SCHOLAR ROCK HOLDING CORP. | 1.3% |
|
SUMMIT THERAPEUTICS INC | 1.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | 1.3% |
|
INSMED INC | 1.2% |
|
EXELIXIS INC | 1.2% |
|
VAXCYTE, INC. | 1.2% |
|
BEAM THERAPEUTICS, INC. | 1.2% |
|
UNITED THERAPEUTICS CORP | 1.2% |
XBI Underweight Relative to SBIO
|
KYMERA THERAPEUTICS, INC. | -3.0% |
|
CRINETICS PHARMACEUTICALS INC | -2.5% |
|
NEWAMSTERDAM PHARMA CO NV | -2.4% |
|
MIRUM PHARMACEUTICALS, INC. | -2.3% |
|
CG ONCOLOGY, INC. | -2.3% |
|
EDGEWISE THERAPEUTICS, INC. | -2.1% |
|
CELCUITY INC. | -2.1% |
|
ALKERMES PLC | -2.0% |
|
TARSUS PHARMACEUTICALS, INC. | -1.8% |
|
DIANTHUS THERAPEUTICS INC | -1.7% |